Characteristics of Clinically Diagnosed Pediatric Myocarditis in a Contemporary Multi-Center Cohort
Ryan J Butts1,2, Gerard J Boyle3, Shriprasad R Deshpande4
1Pediatric Cardiology, Medical University of South Carolina, Charleston, SC, USA. ryan.butts@utsouthwestern.edu.
Insights
This study on pediatric myocarditis found a bimodal age distribution. Gastrointestinal symptoms and reduced echo shortening fraction may predict severe outcomes in hospitalized children.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Research
- Inflammatory Heart Disease
Background:
- Myocarditis is an inflammatory condition affecting the heart muscle in children.
- Accurate diagnosis and risk stratification are crucial for managing pediatric myocarditis.
- Understanding contemporary trends in pediatric myocarditis is essential for clinical practice.
Purpose of the Study:
- To describe a current cohort of pediatric patients hospitalized with suspected myocarditis.
- To identify factors associated with adverse outcomes, including mortality and heart transplantation.
- To evaluate the effectiveness of immunotherapy in pediatric myocarditis.
Main Methods:
- Retrospective chart review of 171 pediatric patients (≤18 years) with suspected myocarditis across seven tertiary hospitals (2008-2012).
- Exclusion criteria included lack of suspected myocarditis or an alternative diagnosis.
- Analysis of demographic data, clinical presentation, treatment, and outcomes, including mortality, transplantation, and readmission.
Main Results:
- Pediatric myocarditis exhibited a bimodal age distribution (24% <2 years, 46% aged 13-18 years).
- No significant difference in mortality, heart transplantation, or readmission was observed between immunotherapy groups (IVIG, steroids, both, or none).
- Gastrointestinal symptoms and lower echocardiographic shortening fraction at admission were associated with increased risk of death or transplantation.
Conclusions:
- Pediatric myocarditis presents with a bimodal age distribution.
- Current immunotherapy regimens (IVIG, steroids) do not appear to influence mortality or transplantation rates.
- Gastrointestinal symptoms and reduced echocardiographic shortening fraction are potential indicators for identifying high-risk pediatric patients with myocarditis.
Abstract:
The objective of this study was to describe a contemporary cohort of pediatric patients hospitalized for clinically suspected myocarditis. A retrospective chart review was performed at seven tertiary pediatric hospitals. Electronic medical records were searched between 2008 and 2012 for patients ≤18 years admitted with an ICD-9 code consistent with myocarditis. Patients were excluded if the admitting or consulting cardiologist did not suspect myocarditis during the admission or an alternative diagnosis was determined. One hundred seventy-one patients were discharged or died with a primary diagnosis of myocarditis. Median age was 13.1 years (IQR 2.1, 15.9), with a bimodal distribution; 24% <2 years and 46% between 13 and 18 years. Patients with moderate or severe systolic dysfunction were younger, had higher BNPs at admission, but had lower troponin. Mortality, heart transplantation, and readmission did not differ between patients who received only IVIG, only steroids, IVIG and steroids, and no immunotherapy. Ninety-four patients (55%) were discharged on heart failure medications, 16 were transplanted, and seven died. The presence at the time of admission of gastrointestinal (GI) symptoms (p = 0.01) and lower echo shortening fraction (SF) (p < 0.01) was associated with death/transplant. Within one year 16% had a readmission, one underwent heart transplant, and 39% received heart failure therapy. Pediatric myocarditis has a bimodal age distribution. The use of IVIG and steroids is not associated with mortality/heart transplantation. The presence of GI symptoms and lower echo SF may identify patients at risk for death and/or transplantation during the admission.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis IV: Nursing Management

